Hochdorf Swiss Nutrition is establishing a joint venture focused on infant formula with Pharmalys Laboratories, according to reports from Yahoo Finance and Just-Food. The venture brings together Hochdorf’s role in dairy and nutrition products with Pharmalys’ existing infant-formula business. Both outlets describe the announcement as a move to develop and expand infant-formula activities through a dedicated partnership structure. The coverage is focused on the formation of the joint venture itself, rather than providing detailed information on the parties’ ownership stakes, financial terms, geographic scope, or expected production timelines. Overall, the reports agree that the transaction involves creating a new vehicle to support infant-formula operations under the combined expertise of the two companies.
Hochdorf Swiss Nutrition forms infant-formula joint venture with Pharmalys
Hochdorf Swiss Nutrition is establishing a joint venture focused on infant formula with Pharmalys Laboratories, according to reports from Yahoo Finance and Just-Food. The venture brings together Hochd...
- Hochdorf Swiss Nutrition forms an infant-formula joint venture.
- The JV partner is Pharmalys Laboratories.
- The venture is intended to focus on infant-formula business activities.
- Reports present the announcement as a new partnership structure.
- Details such as ownership stakes and financial terms are not provided in the cited summaries.
Dairy group Hochdorf is setting up a venture with infant-formula business Pharmalys Laboratories. The post Hochdorf Swiss Nutrition forms infant-formula JV with Pharmalys appeared first on Just Food.
23 hours ago
Family conned by DJ Carey sells All-Ireland medal to aid victims
The family affected by fraud allegations involving DJ Carey is selling an All-Ireland medal tied to a former hurler to s...
Perth paediatrician charged with additional child sex offences against seven more victims
A Perth paediatrician is charged with additional child sexual offences involving seven more alleged victims. Multiple re...
FDA approves Moderna’s first mRNA seasonal flu vaccine for adults 50 and older
The U.S. Food and Drug Administration (FDA) has approved Moderna’s mRNA-based seasonal influenza vaccine, mFlusiva, mark...